Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density

Clinical Microbiology and Infection

Volumn 19, Issue 6, 2013, Pages

  Huijbers, P M C ^a,b   de Kraker, M ^a   Graat, E A M ^b   van Hoek, A H A M ^a   van Santen, M G ^a   de Jong, M C M ^b   van Duijkeren, E ^a   de Greeff, S C ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Extended spectrum lactamase; Humans; Poultry; Prevalence; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BROILER; CONTROLLED STUDY; DISEASE CARRIER; DISEASE TRANSMISSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HORSE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ANIMALIA; ENTEROBACTERIACEAE; EQUIDAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BETA-LACTAMASES; CHICKENS; CITIES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION DENSITY; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84876785979     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12150     Document Type: Article

References (19)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(Suppl 1): i3-i10.
2. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873-880.
3. Overdevest I, Willemsen I, Rijnsburger M et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 2011; 17: 1216-1222.
4. Vinué L, Sáenz Y, Martínez S et al. Prevalence and diversity of extended-spectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954-956.
5. Geser N, Stephan R, Korczak BM, Beutin L, Hächler H. Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2012; 56: 1609-1612.
6. EFSA (European Food Safety Authority). Scientific opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA J 2011; 9: 1-90.
7. Dierikx CM, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D. Increased detection of extended-spectrum β-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol 2010; 145: 273-278.
8. Hartmann A, Locatelli A, Amoureux L et al. Occurrence of CTX-M producing Escherichia coli in soils, cattle, and farm environment in France (Burgundy region). Front Microbiol 2012; 3: 83.
9. Dierikx CM, van Duijkeren E, Schoormans A et al. Occurrence and characteristics of extended-spectrum-β-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses. J Antimicrob Chemother 2012; 67: 1368-1374.
10. Smet A, Martel A, Persoons D et al. Comparative analysis of extended-spectrum β-lactamase-carrying plasmids from different members of Enterobacteriaceae isolated from poultry, pigs and humans: evidence for a shared β-lactam resistance gene pool? J Antimicrob Chemother 2009; 63: 1286-1288.
11. Smet A, Rasschaert G, Martel A et al. In situ ESBL conjugation from avian to human Escherichia coli during cefotaxime administration. J Appl Microbiol 2011; 110: 541-549.
12. Dierikx CM, Van der Goot J, Fabri T, van Essen-Zandbergen A, Smith H, Mevius D. Extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing Escherichia coli in Dutch broilers and broiler farmers. J Antimicrob Chemother 2012; 68: 60-67.
13. Thrusfield M, Ortega C, De Blas I, Noordhuizen JP, Frankena K. Win episcope 2.0: improved epidemiological software for veterinary medicine. Vet Rec 2001; 148: 567-572.
14. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 21st Informational Supplement M100-21. Wayne, PA: CLSI, 2011.
15. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. Hoboken, New Jersey: John Wiley & Sons, Inc., 2000.
16. Tängdén T, Cars O, Melhus Å, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-3568.
17. Ben-Ami R, Rodríguez-Baño J, Arslan H et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682-690.
18. Ben Sallem R, Ben Slama K, Estepa V et al. Prevalence and characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 1511-1516.
19. Luvsansharav UO, Hirai I, Niki M et al. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011; 17: 722-725.